Infectious Disease

A Wealth of Experience

We have collaborated with our clients on projects to research infectious disease, infectious disease treatment, and complications and comorbidities of infectious disease.  Our experience includes:

  • Cholera
  • COVID-19
  • H1N1
  • Hepatitis
  • Herpes
  • Hospital-acquired infections
  • Human papillomavirus
  • Influenza
  • Invasive fungal infections
  • Malaria
  • Meningococcal disease
  • MRSA
  • Respiratory tract infections
  • Respiratory syncytial virus (RSV)
  • STDs
  • Vaccines

Types of Projects

We have implemented studies to help our clients develop strategies in the infectious disease market and to develop and gain market access for products to treat infectious diseases and complications arising from treatment of infectious diseases.

Recent projects have included:

Our Experts

Jin Yang
Associate Director, Market Access and Outcomes Strategy
Carla DeMuro
Executive Director, Patient-Centered Outcomes Assessment
Anita Brogan
Vice President, Decision Analytic Modeling, Health Economics
Josephine Mauskopf
Vice President, Health Economics
Elizabeth B. Andrews
Vice President, Emeritus, Epidemiology
Maria Fernandez
Senior Director, Market Access and Outcomes Strategy
Alejandro Arana
Senior Director, Epidemiology
Kati Copley-Merriman
Vice President, Market Access and Outcomes Strategy
Dee Dee Mladsi (she/her)
Vice President, Health Economics—Strategy and Early Modeling
Bintu Sherif
Director, Biostatistics
Marco Boeri
Senior Economist
Alicia Gilsenan
Vice President, Epidemiology
Catherine Masaquel
Senior Director, Market Access and Outcomes Strategy
Keith Davis
Senior Director, Health Economics
Stephanie Earnshaw
Senior Vice President, Health Economics
Michele Wilson
Senior Director, Health Economics
Jonathan Graham
Director, Health Economics
Sandra Talbird
Senior Director, Health Economics
Katherine Hicks
Senior Director, Health Economics
William L Herring
Senior Director, Health Economics
Juliana Meyers
Director, Health Economics
Lynda Doward
European Head, Patient-Centered Outcomes Assessment
Christine Poulos
Senior Economist and Global Head, Health Preference Assessment
Annete Njue
Senior Director, Market Access and Outcomes Strategy